Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Alcohol is responsible for a significant portion of global disease and death, contributing to 2.6 million deaths annually. It ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...